• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

ValGan Not Happening ... Here's Why

Before Ackman started buying AGN the value was 110. By the time Ackman stopped the value was around 142. Once Pershing made the stake public, AGN jumped to 172 and now is at 166. Ackman's average price was 126. If ValGan does not go through and Ackman started selling AGN, it will be very difficult for him to sell at an average price above 126. Hence Ackman is looking at loss if he does a fire sell.

In absence of ValGan deal, AGN falls back to 120. This represents a loss of 45 which is very close to the amount Valeant is offering as cash.

So Valeant is creating a 15 billion debt and giving money to AGN shareholders. And then Valeant is giving AGN shareholders .83 % of ValGan stock. This ValGan entity will have no pipeline and hence no blockbusters and will be saddled with 32 billion debt.

I want to know which foolish shareholder likes this deal other than Ackman
 




In absence of ValGan deal, AGN falls back to 120. This represents a loss of 45 which is very close to the amount Valeant is offering as cash.

So Valeant is creating a 15 billion debt and giving money to AGN shareholders. And then Valeant is giving AGN shareholders .83 % of ValGan stock. This ValGan entity will have no pipeline and hence no blockbusters and will be saddled with 32 billion debt.

I want to know which foolish shareholder likes this deal other than Ackman

Love to see AGN take out a multi billion credit line and do couple of hostile takeovers in Ireland. That will make Valeant go away
 




The company will sell to someone. The board doesn't care about culture history etc Why do you think they opened it up to hear more offers? They are looking for a even better deal. It's business. The old Allergan will be no more. I hope it goes to J&J at least the R&D model may stay the same.
 




The company will sell to someone. The board doesn't care about culture history etc Why do you think they opened it up to hear more offers? They are looking for a even better deal. It's business. The old Allergan will be no more. I hope it goes to J&J at least the R&D model may stay the same.

Anyone but Valeant. They are absolutely the worst.
 








Lots of opinions out here on this board! All the "board" experts! Don't think this deal will go through at all. That's my opinion

I hope you're right, but given Allergan's silence and lack of effort in talking shareholders out of the deal, I wonder if they are underestimating Valeant and Ackman's manipulation and bullying techniques.

According to the latest report on Valeant's meeting today, they want to call a shareholder referendum to "gauge support" and start to remove board members. Apparently, they've been holding meetings with AGN shareholders (of which many are also VRX shareholders?) and claim that many support the acquisition going through.
 












I hope you're right, but given Allergan's silence and lack of effort in talking shareholders out of the deal, I wonder if they are underestimating Valeant and Ackman's manipulation and bullying techniques.

According to the latest report on Valeant's meeting today, they want to call a shareholder referendum to "gauge support" and start to remove board members. Apparently, they've been holding meetings with AGN shareholders (of which many are also VRX shareholders?) and claim that many support the acquisition going through.




I think the silence is more a positive for AGN and employees than speaking out about the proposed buy. Why give VRX any idea what we are planning or thinking????? What is the point of that. AGN has been a fruitfall company for along time and you have to believe as Pyott said that they have anticipated this day for sometime and have prepared for it. If AGN wanted this deal, then you would hear AGN talking publically about it. This is a chess game at this point and the longer AGN holds off, the more it antagonises Ackman.
 




I think the silence is more a positive for AGN and employees than speaking out about the proposed buy. Why give VRX any idea what we are planning or thinking????? What is the point of that. AGN has been a fruitfall company for along time and you have to believe as Pyott said that they have anticipated this day for sometime and have prepared for it. If AGN wanted this deal, then you would hear AGN talking publically about it. This is a chess game at this point and the longer AGN holds off, the more it antagonises Ackman.

I'm sorry, tough to follow your train of thought. Your spelling and grammar is like reading a kindergartener.
 




I think the silence is more a positive for AGN and employees than speaking out about the proposed buy. Why give VRX any idea what we are planning or thinking????? What is the point of that. AGN has been a fruitfall company for along time and you have to believe as Pyott said that they have anticipated this day for sometime and have prepared for it. If AGN wanted this deal, then you would hear AGN talking publically about it. This is a chess game at this point and the longer AGN holds off, the more it antagonises Ackman.

Oh, I don't mean publicly antagonizing VRX, but some kind of behind the scenes lobbying of major shareholders to support AGN's stance. Don't know if that would work well obviously, but apparently JP Morgan used this tactic against activist shareholders.
 




The slower the process is, and the more silent AGN is, the better for AGN. Valeant can't afford for this to drag on with its lousy nonorganic growth. The longer this takes the more time it allows investors to realize that this is not a good deal at all. So expect it to drag on and for Valeant to suffer more as a result.
 
















I think the silence is more a positive for AGN and employees than speaking out about the proposed buy. Why give VRX any idea what we are planning or thinking????? What is the point of that. AGN has been a fruitfall company for along time and you have to believe as Pyott said that they have anticipated this day for sometime and have prepared for it. If AGN wanted this deal, then you would hear AGN talking publically about it. This is a chess game at this point and the longer AGN holds off, the more it antagonises Ackman.


Who the fuk did Pyott say that to? They knew 19 months ago about this potential merger and said nothing to AGN! Btn that time and now Billy Ackman bought 10 percent of our company! There is nothing to say publicly besides Sorry and God Speed!
 








Ok all fair arguments, but if you could give him a grade A-F for how he has handled this, what would you give him? Sanofi and JNJ are dead and our shareholders tend to lean towards making more money so that eliminates the BS poison pill. That's the problem with this company no balls! What grade would you give him?
 




Ok all fair arguments, but if you could give him a grade A-F for how he has handled this, what would you give him? Sanofi and JNJ are dead and our shareholders tend to lean towards making more money so that eliminates the BS poison pill. That's the problem with this company no balls! What grade would you give him?

I would grade him A minus. My reasons are below

Good things like
Past Achievements
Current Progress
Future Vision
Clarity of thought

Reasons for not giving A Plus
Senior management did not allocate capital wisely
Inversion should have been executed atleast 2 years ago
In current situation, employees are out of loop